Mixed gel

Mammary FSK-3 cells plated onto matrix pads consisting of rat mammary ECM isolated from a nulliparous mouse, treated with 24hr pulse of BrdU and processed for immunohistochemical detection. Credit: Pepper Schedin / University of Colorado Health Sciences Center" />Mammary FSK-3 cells plated onto matrix pads consisting of rat mammary ECM isolated from a nulliparous mouse, treated with 24hr

Written byJosh P. Roberts
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

User:
Pepper Schedin, University of Colorado Health Sciences Center, Denver

Project:
Relating life-cycle stages (such as pregnancy, lactation, and menopause) in the mammary gland stroma to tumor dormancy and progression

Problem:
Like Cukierman, Schedin looks at interactions of different ECMs with tumors. Schedin, though, extracts ECM from whole tissue; here, the resulting solution is too dilute to polymerize on its own - about 1/10 to 1/20th the concentration of Matrigel. Protocols to concentrate the ECM end up concentrating cellular contaminants along with it.

Solution:
Mixing the extracted ECM solutions 1:1 (volume to volume) with Matrigel allows the solution to polymerize.

While the resulting 3-D scaffold on which tumor cells are cultured is not the pure ECM they would see in vivo, for her experiments Schedin doesn't worry about the effects of the Matrigel itself. Matrigel "essentially becomes an even background" against which the effects of using ECM isolated from virgin, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies